Amit M Algotar

Interests

Teaching

Cancer survivorship,Cancer epidemiology and prevention,Obesity and metabolic diseases,Relationship of obesity and metabolic diseases with cancer

Research

Cancer survivorship,Cancer epidemiology and prevention,Obesity and metabolic diseases,Relationship of obesity and metabolic diseases with cancer

Courses

Scholarly Contributions

Chapters

• Algotar, A. (2018). Prostate Cancer Prevention. In Frontiers in cancer prevention.

Journals/Publications

• Algotar, A., Trophymenko, S., Howerter, A., Muramoto, M. L., & Kutob, R. M. (2022). Medical group visits are effective in achieving weight loss and blood pressure control in an underserved population. Medicine.
• Algotar, A., Hsu, C., Abraham, I. L., Marrero, D., Thomson, C. A., & Chow, H. (2019). Comprehensive lifestyle improvement program for prostate cancer (CLIPP): Protocol for a feasibility and exploratory efficacy study in men on androgen deprivation therapy. Journal of Medical Internet Research.

Proceedings Publications

• Abraham, I. L., MacDonald, K., McBride, A., Algotar, A., Babiker, H. M., Martin, J. R., Katragadda, C., Alsaid, N., & Fletcher, S. (2018, Spring). Risk of biochemical recurrence in prostate cancer patients with perineural invasion: systematic review and meta-analysis.. In Journal of Clinical Oncology, 36(Suppl), e21671..

Poster Presentations

• Algotar, A. (2021). Effect of comprehensive lifestyle modification intervention on health related quality of life in prostate cancer survivors on androgen deprivation therapy.. American Society for Preventive Oncology.
  More info

  Algotar A. M., Babiker H. M., Dougherty S.T., Hsu C.H., Marrero D.G., T.E. Smith, Jones P.A. Lopes J.N., Abraham I., Kumar R., Ligibel J.A., Courneya K.S., Ramakumar S., Hoy. R.D. Mack C., Thomson C.A.
• Algotar, A. (2021). Lifestyle intervention reduces weight and preserves lean body mass in men on androgen deprivation therapy for prostate cancer.. American Society for Preventive Oncology.
  More info

  Lopez JN, Smith TE, Jones PA, Hsu CH, Chow H-H, Dougherty ST, Babiker HM, Marrero DG, Abraham I, Kumar R, Ligibel JA, Courneya KS, Niemiro G, Ramakumar S, Hoy RD, Mack C, Thomson CA, Algotar A.M.
• Algotar, A., & Babiker, H. M. (2019, February). Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): A feasibility study in men with prostate cancer on ADT. ASCO Genitourinary Cancers Symposium.
• Algotar, A., Hsu, C., Chow, H., Abraham, I. L., Babiker, H. M., Marrero, D., Dougherty, S., Babiker, H. M., Kumar, R., Ligibel, J., Courneya, K. S., & Thomson, C. A. (2019, Spring). Comprehensive lifestyle improvement program for prostate cancer (CLIPP): A feasibility study in men with prostate cancer on ADT.. Genitourinary Cancers Symposium.
• Tapia, E., Villa Guillen, D., Chalasani, P., Centuori, S., Roe, D., Guillen-Rodriguez, J., Huang, C., Galons, J., Thomson, C. A., Altbach, M. I., Trujillo, J., Pinto, L., Martinez, J. A., Algotar, A., & Chow, H. (2020, Fall). Effects of metformin on breast density and anthropometric measurements in premenopausal women with components of metabolic syndrome: Findings from a Phase II randomized, double-blind, placebo-controlled trial.. University of Arizona Cancer Center Fall Retreat.
  More info

  Tapia E, Villa Guillen D, Chalasani P, Centuori S, Roe D, Guillen-Rodriguez J, Huang C, Galons JP, Thomson CA, Altbach M, Trujillo J1, Pinto L, Martinez JA, Algotar AM,, Chow S. Effects of metformin on breast density and anthropometric measurements in premenopausal women with components of metabolic syndrome: Findings from a Phase II randomized, double-blind, placebo-controlled trial. UACC Fall Retreat. (November 2020).
• Algotar, A. (2020). Lifestyle intervention reduces weight and preserves lean body mass in men on androgen deprivation therapy for prostate cancer.. Prostate Cancer Foundation.
  More info

  Lopez J.N., Smith T.E., Jones P.A., Hsu C.H., Chow H-H, Dougherty S.T., Babiker H.M., Marrero D.G., Abraham I., Kumar R., Ligibel J. A., Courneya K.S., Niemiro G., Ramakumar S., Hoy R.D., Mack C., Thomson C.A.,
• Thomson, C. A., Courneya, K. S., Ligibel, J., Kumar, R., Babiker, H. M., Dougherty, S., Marrero, D., Babiker, H. M., Abraham, I. L., Chow, H., Hsu, C., & Algotar, A. (2019, Spring). Comprehensive lifestyle improvement program for prostate cancer (CLIPP): A feasibility study in men with prostate cancer on ADT.. ASCO Genitourinary Cancers Symposium.
• Aldama, J., Armin, J. S., & Algotar, A. (2018, March). Engaging key stakeholders to understand prostate cancer survivor preferences for and perceived barriers to a lifestyle modification intervention. American Society for Clinical Oncology Annual Meeting. NY, NY: American Society for Clinical Oncology.
• Algotar, A. (2018, June). Risk of biochemical recurrence in prostate cancer patients with perineural invasion: systematic review and meta-analysis.. ASCO Annual Conference.
• Algotar, A. (2018, Sept). Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): A feasibility study in men with prostate cancer on ADT. University of Arizona Scientific Retreat.
• Algotar, A., Algotar, K., Rosenberg, A., & Sanft, T. (2018, February). Disconnect between physical activity guidelines and ground reality: A real world analysis of physical activity profile of cancer survivors. Cancer Survivorship Symposium: Advancing Care and Research. Orlando, FL: American Society for Clinical Oncology.
• Chow, H., Algotar, A., Altbach, M. I., Galons, J., Roe, D., Thomson, C. A., Guillen-Rodriguez, J. M., Martinez, J. A., Chalasani, P., Villa Guillen, D. E., Tapia, E. O., Trujillo, J., Chow, H., Algotar, A., Altbach, M. I., Galons, J., Roe, D., Thomson, C. A., Guillen-Rodriguez, J. M., , Martinez, J. A., et al. (2018, Fall). Abstract: Phase II clinical study of metformin for breast cancer prevention. UACC Scientific Retreat. UACC Scientific Retreat. Tucson, AZ.
• Chow, H., Algotar, A., Roe, D., Miller, J., Gallons, J. P., Altbach, M., Thomson, C. A., Chalasani, P., Cordova, C., Tapia, E., Villa-Guillen, D. E., Trujillo, J. S., Chow, H., Algotar, A., Roe, D., Miller, J., Gallons, J. P., Altbach, M., Thomson, C. A., , Chalasani, P., et al. (2018, March 2018). The potential for metformin to reduce obesity-associated breast cancer risk. American Society for Preventive Oncology, 42nd Annual Conference. New York: American Society for Preventive Oncology.
• Thomson, C. A., Smith, T., Hsu, C., Dougherty, S. T., Babiker, H. M., Chow, H., Marrero, D., & Algotar, A. (2018, Fall). Abstract: Comprehensive lifestyle improvement program for prostate cancer (CLIPP) Survivors. UACC Scientific Retreat. Tucson, AZ.
• Algotar, A. (2017, March). TRENDS OF E-CIGARETTE USE IN VETERANS ENROLLED IN TOBACCO-DEPENDENCE TREATMENT, VETERANS AFFAIRS LOMA LINDA HEALTHCARE SYSTEM, LOMA LINDA, CA, 2015- 2016. Society for Research on Nicotine and Tobacco, 2017. Florence, Italy: Society for Research on Nicotine and Tobacco.
• Algotar, A. (2017, May). Medical group visits are effective in achieving weight loss in an underserved population. Preventive Medicine 2017. Portalnd, OR: American College of Preventive Medicine.
• Algotar, A., Howerter, A., Kutob, R. M., & Muramoto, M. L. (2017, Oct/2017). Group visits are effective in lowering blood pressure in an under served population. American College of Lifestyle Medicine Annual Conference. Tucson, AZ: American College of Lifestyle Medicine.